Trial
NCT00418782
A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
—
Condition
Osteoarthritis
Intervention
naproxen
Why stopped
Results of interim analysis indicate lack of efficacy when compared to placebo.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-05